Lenz Therapeutics, Inc. · NASDAQ:LENZ
Versant Venture Capital VI, L.P. reported a 7.50% stake in Lenz Therapeutics, Inc. (Schedule 13D/A)
Event Jun 10, 2025 · Filed Jun 12, 2025
Versant Venture Capital VI, L.P. reported a 7.50% stake in Lenz Therapeutics, Inc., 2,101,199 shares, with active intent on Jun 10, 2025. Filed Jun 12, 2025 (Schedule 13D/A).
- Stake
- 7.50%
- Shares
- 2,101,199
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 9 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Versant Venture Capital VI, L.P. | 7.50% | 2,101,199 |
| Versant Ventures VI GP, L.P. | 7.50% | 2,101,199 |
| Versant Ventures VI GP-GP, LLC | 7.50% | 2,101,199 |
| Versant Vantage II, L.P. | 3.00% | 842,162 |
| Versant Vantage II GP, L.P. | 3.00% | 842,162 |
| Versant Vantage II GP-GP, LLC | 3.00% | 842,162 |
| Versant Venture Capital VII, L.P. | 4.70% | 1,319,323 |
| Versant Ventures VII GP, L.P. | 4.70% | 1,319,323 |
| Versant Ventures VII GP-GP, LLC | 4.70% | 1,319,323 |
Source
Related
- Lenz Therapeutics, Inc.
- Versant Venture Capital VI, L.P.
- Lenz Therapeutics, Inc. shareholders
- Schedule 13D/A · Versant Venture Capital VI, L.P. · Nov 10, 2025
- Schedule 13D/A · Versant Venture Capital VI, L.P. · Sep 22, 2025
- Schedule 13D/A · Versant Venture Capital VI, L.P. · Aug 20, 2025
- Schedule 13D/A · Versant Venture Capital VI, L.P. · Jul 14, 2025
- Schedule 13D/A · Versant Venture Capital VI, L.P. · Jun 24, 2025
- Schedule 13G/A · Millennium Management LLC · Oct 21, 2026
- Schedule 13G/A · FMR LLC · Sep 8, 2026
- Schedule 13G · Millennium Management LLC · Jun 26, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G · Squarepoint Ops LLC · Apr 8, 2026